MIRIS HOLDING AB
NNGM:MIR19.30
SEK
0.00
(0.00%)
MIRIS HOLDING AB
NGM:MIR
(Nordic Growth Market)
Recent
price
19.30
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Miris Holding AB is a Sweden-based medical device company that develops, manufactures, and commercializes analytical instruments and consumable solutions for human milk analysis and individualized neonatal nutrition. Founded in 2006 and headquartered in Uppsala, Sweden, the company specializes in mid-infrared spectroscopy technology to support targeted nutritional care for preterm and critically ill infants in clinical environments. Miris Holding AB operates through a comprehensive product portfolio comprising the Miris Human Milk Analyzer (Miris HMA), an FDA-cleared analytical instrument designed to measure the macronutrient concentrations of human breast milk, including fat, crude protein, true protein, carbohydrate, dry matter, and energy content; the Miris Ultrasonic Processor, an ultrasonic sonication device utilized for the homogenization of milk samples prior to spectroscopic measurement; the Miris Heater, a sample heating system designed to preheat milk to optimal testing temperatures; and specialized consumables and maintenance solutions, including Miris Cleaner, Miris Check, and Miris Calibration Control liquids for daily quality assurance, instrument calibration, and cleaning protocols. The company also provides customer support services, clinical training programs, technical maintenance, and extended warranty packages. Miris Holding AB primarily serves neonatal intensive care units (NICUs), pediatric hospitals, human milk banks, maternity clinics, and academic research institutions across North America, Europe, Asia-Pacific, and the Middle East, distributing its products through a combination of direct sales forces and independent distributor networks. In recent developments, Miris Holding AB has advanced its commercial expansion across the United States healthcare market following its regulatory authorization, strengthened its international distributor partnerships in European and Asian markets, and completed capital financing rounds, including rights issues, to support operational growth and working capital needs. Additionally, the company has undertaken strategic operational and corporate governance realignments to optimize its supply chain and ensure sustained regulatory compliance under the European Union Medical Device Regulation (MDR) framework.